WeedLife News Network

The decision to take an early-morning drive with cannabis debris clearly visible inside his vehicle turned out to be a bad one for a 20-year-old California man with a weed-sounding moniker.This past Saturday proved anything but relaxing for Kody Idica — just one letter shy of Indica, a cannabis variety long associated with sedating effects — when police stopped his vehicle at about 3:30 a.m. in Redwood Valley, Calif.

That find prompted a search of the vehicle, where the officer “found other evidence associated with the transportation and sale of illicit drugs.”

Recreational cannabis is legal in California, with adults 21 and older able to buy, possess and consume up to 28.5 grams of weed in their private residence or an establishment that has been licensed for consumption, FindLaw reports. The drug can not be consumed, whatever the method used, when a vehicle is in motion, adds Chambers Law Firm.

Under the Controlled Substance Act, first offenders for possessing cocaine could face imprisonment for as long as a year and a fine ranging from US$1,000 ($1,260) and US$100,000 ($126,000). Penalties increase with second or third convictions, according to McElfresh Law Inc.

When the U.S. government eventually legalizes marijuana, there will undoubtedly be a lot more businesses looking to expand into the growing industry. The current federal ban on pot means that large companies with robust logistical abilities don't generally see the point of getting involved, since marijuana can't cross state lines. But there's hope that with Senate Majority Leader Chuck Schumer leading the charge and pushing for marijuana reform (which includes legalization), significant changes could be coming soon.

Want to know how I know that weed is going to be legalized on a federal level fairly soon Insurers are getting ready. That’s right! One of these days you’ll be able to get weed insurance on your crops, cannabis-related business ventures and much more.

There is no denying that cannabis is BIG business. Some estimates believe that by 2026 the cannabis industry could hit $41b annually. Despite the yearly earnings for the cannabis industry, insurers only wrote out about 250 million in policies and in many cases are charging far more than typical retailers with extreme limits in place.

This might not be of significant importance to consumers, but if insurers do get a chance to play with the cannabis industry, it could revolutionize the industry within a matter of months.

When Colorado became the first state to legalize recreational marijuana in 2012, it didn't have a playbook.

While the state worked out the early rules regarding sales and taxation, it didn't initially consider how years of marijuana criminalization had impacted historically marginalized communities, and whether those communities should get special access to opportunities in the cannabis industry. (As originally posted on Westword by HILAL BAHCETEPE)

But in the years that followed, other states that legalized recreational marijuana did consider those issues and built social equity provisions into their programs.

Colorado is now playing social equity catch-up. On October 1, Governor Jared Polis pardoned 2,732 past marijuana possession convictions. When he signed Senate Bill 111 earlier this year, he approved $4 million going to support social-equity marijuana entrepreneurs. And on April 20 — that unofficial stoner holiday – Mayor Michael Hancock signed into law Denver’s social equity program, which began accepting applications for licenses in June.

The more a person uses cannabis, the more likely it will be to develop a tolerance. As with many other substances, cannabis tolerance occurs naturally as the body gets used to weed and reduces its response to the drug.

While tolerance may be a fix for such issues as bad highs, wild munchies and paranoia, it usually also ushers in a new set of problems.Fortunately, cannabis tolerance is a fairly simple enough problem to solve.

Tolerance breaks are popular for a reason, and by taking a break from weed for a couple of weeks, the body is likely to experience a stronger and revitalized response to the drug.

It’s best to keep an eye out for these three problems associated with developing a high THC tolerance.

Less therapeutic effect

Developing a high tolerance for cannabis means that a person won’t get as high as previously. For everyday users, this can be a bummer, but for people who use cannabis for therapeutic or relief purposes, it’s likely to be more significant.

As different as they may seem, there's some overlap between the cannabis industry and biotech that's worth understanding as an investor. Cultivators can use biotechnology to manipulate the genes of marijuana plants to increase their yield, and biotechs can use the bioactive chemicals contained in cannabis as jumping-off points for drug development efforts. 

Both of the companies I'll analyze today conduct their business within these overlapping regions. And, if their efforts continue to pan out as planned, they'll be valuable stocks to own, especially as the biotech sector becomes more sophisticated and as the cannabis industry scales to match global demand. 

There is a major debate about the loss of Afghanistan, but for the most part, it has followed the Prime Directive: “Don’t mention the Drug War!”

Nonetheless, it seems relevant that Afghanistan is still the world’s largest opium poppy producer.

According to Reuters, “Despite the threats posed by Afghanistan’s illicit drug business, experts noted, the United States and other nations rarely mention in public the need to address the trade, estimated by the UNODC at more than 80% of global opium and heroin supplies.”

So, we controlled the country? And our Drug War was subsidizing the Taliban?

This summer three U.S. senators released a discussion draft of legislation that would remove cannabis from the schedule of controlled substances under federal law and provide for federal taxation of cannabis products. Greg Kaufman of Eversheds Sutherland outlines the key provisions and urges lawmakers to consider data collected at the state level to get it right.

Currently, 18 states and the District of Columbia have the broadest allowances for marijuana use, legalizing medical and adult recreational use; a handful of other states have passed legislation allowing medical marijuana.

Overall, 47 states have some form of cannabis allowance, only Idaho, Kansas and Nebraska do not have any public programs for marijuana use. But marijuana laws and programs remain a highly contested topic and often see modifications as political power changes. (See also: State Marijuana Laws from 2019 Map)

Earlier this year, Mississippi overturned a 2020  medical-use marijuana measure, which could make the state’s already limited laws even tighter. South Dakota, which currently allows medical marijuana use, ruled earlier this year that a 2020 measure for nonmedical usage was unconstitutional and is awaiting appeal. Colorado, the first state to legalize marijuana in 2012, will limit high-potency concentrates in 2022 in an effort to decrease teenagers’ access to cannabis. But other states, including Alabama and Virginia, saw expansions of their marijuana programs within the last 18 months and Connecticut was the latest state to legalize recreational use of cannabis with the passage of SB 1201 in June.

Despite most states approving its use, marijuana is still considered a Schedule I illegal substance by federal law. But pressure is mounting to legalize cannabis nationally as the industry grows. Insurance lenders, testing labs and retailers are eager to keep up with the increasing demand (some businesses were even offering free weed as an incentive for getting vaccinated against COVID-19). Legal cannabis sales increased 45 percent last year and are predicted to reach $41 billion by 2026, but until there are federal policies, states will be left to determine how they will navigate the growing business.

Medicinal Marijuana

Psoriasis is a chronic medical condition that has severe implications on an individual’s physical and mental health, which is why the treatment plan has to be holistic and practical.

Approximately 125 million people worldwide have psoriasis. The widespread prevalence of this skin condition makes it a global health concern, which is why experts have been working rigorously to find a solution for this disease.

There is no proven cure for psoriasis, but there are some ways to treat or manage the symptoms of this disease. One solution that has been discovered recently and has become increasingly popular is CBD oils on the skin affected by psoriasis to heal and consume the CBD oil orally to help with the immune system.

If you have psoriasis and are looking into using CBD oil for your treatment, wondering what the possibilities of this treatment are, here is all the information you need to make up your mind and understand this new medical approach. Let’s talk about the symptoms of psoriasis and how CBD oils can target them before discussing the effectiveness of CBD oils in treating psoriasis.

It almost goes without saying that the cannabis industry is one of the fastest growing verticals in the United States, offering a variety of opportunities for existing or prospective corporations, management services organizations (MSO), business owners and developers as many seek to capitalize on the continued state deregulation of medical and recreational cannabis. In the face of global shutdowns, shelter in place orders, loss of jobs and the ever-present threat of illness, cannabis sales skyrocketed in 2020. A study conducted by Leafly, using state tax and revenue data, showed cannabis sales were up 71 percent over 2019 to the tune of $18.3 billion – a $7.6 billion increase. To date, 19 states have legalized marijuana recreationally, while 36 states have medicinal programs. Some jurisdictions are just now issuing licenses, and more are coming online.

Marijuana’s continued status as a Schedule I drug on a federal level certainly doesn’t make it an easy landscape for prospective newcomers to navigate. Whether you already operate a facility or hoping to open a dispensary, processing or grow operation, there are many regulations to keep in mind – most of which also dictate electronic and physical security requirements. Below we discuss a few ways cannabis grow operators, dispensaries and processors can leverage a video management system (VMS) as a part of their overall open platform security plan.

Licensing Requires a Security Plan

Like any business operation, cannabis requires certain licenses, approvals and audits before you can open your doors. While every state’s regulations and security requirements differ, almost all of them require some form of electronic alarm and surveillance system and audit trails, be it paper or electronic, that must be archived.

Every state, and in some cases, even individual cities or municipalities, that has legalized medical or recreational marijuana has stringent licensing requirements that you must meet before you open, whether you’re a grow operation, edible manufacturer, processing plant, dispensary, or in transportation and the newer delivery services. While these regulations may be different, in almost all cases, it includes having an acceptable security plan in place.

Delta 9 Cannabis Inc. (OTCMKTS: DLTNF) has announced the appointment of David Kideckel to the newly created EVP Head of Strategy, Corporate Development & Capital Markets position to spearhead the company’s next growth expansion phase. David has around 20 years of combined experience in capital markets and industry. 

Delta 9 appoints David Kideckel to head the expansion phase 

Delta 9 CEO John Arbuthnot said, “I am extremely pleased to welcome David to our team, propelling our capital markets strategy and reach, through his wealth of experience. David was one of the leading cannabis analysts and has an exceptional network of contacts with an in-depth knowledge of the cannabis industry and its subsectors. David’s appointment reflects our commitment to having best-in-class talent to advance the Company’s growth trajectory strategically and expeditiously.”

David commented, “Of all the companies I have evaluated over the last several years, Delta 9 has incredible potential and I’m proud to join a seasoned team that is on the verge of steady and continuous growth within an explosive industry.”

Amyris launches first of the Terasana Clinical skincare products 

Amyris Inc. (NASDAQ: AMRS) has launched the Terasana Clinical clean skincare brand. The launch is the first of the three brand launches the company anticipates launching this summer. The first skincare brand, Clear + Control Healthy Skin Serum, addresses irritation, skin flaking, dry skin, and redness. The proprietary formulation in the product combines Cannabigerol (CBG) and Squalane. 

CEO John Melo said, “CBG has a variety of proven skin benefits and through our well-established fermentation technology, we are able to manufacture CBG at scale and at a much lower cost than existing alternatives. We believe that clean CBG has opened up new avenues for innovation in sustainable and effective skincare and that it has the potential to be a breakthrough in addressing the acne market. We are on track to launch three new clean beauty consumer brands this month.”

New Israeli clinical trials will examine the safety and efficacy of cannabis-based treatments for some of the most painful and persistent gynecological conditions faced by women.

The trials, expected in early 2022, will test cannabis-based pharmacology products developed by Gynica, a Jerusalem-based femtech (female technology) startup that believes that the active ingredients in the plant can ease painful conditions in the female reproductive system such as dysmenorrhea, or painful menstruation, and endometriosis.

Conventional treatments like over-the-counter painkillers, hormone therapy, and even surgical intervention can be insufficient or even pose their own health detriments in the case of endometriosis, an often agonizing disorder that occurs when tissue similar to that which normally lines the uterus – the endometrium – begins to grow outside the organ.

Gynica says it is hoping to meet unaddressed needs in women’s health by developing cannabis-based solutions for these conditions.

BROOMFIELD, Colo., Aug. 25, 2021 /PRNewswire/ -- As we move into the future, we not only need to look at planetary solutions, but interplanetary ones as well. Owner and CEO of Key to Life Supply, Tate Dooley, not only understands this future need, but remains a forward-thinker and industry leader in conceptualizing how this process will work. Tate has been quoted as saying "We will not stop until we have a lab on the moon!"

So, where does cannabis fit into this dream? Well, the future of the cannabis industry is not only bright, but its possibilities are nearly endless! Not only is it a medicine, but in the form of hemp, it can also be a source of food and protein, a building material, a soil rejuvenator, a source of fiber for clothing and rope, a replacement for plastics, a producer of oil, and many other things that would take pages and pages to describe. This not only means a decrease in slow-growing sources of materials like trees, but it also means a diversification of new jobs, new income, new infrastructure and a second chance to consider logistics and transportation possibilities.

The considerable income from this movement can also lead to more research into genetics, genetic potential, soil regeneration practices, and research into the interplanetary endeavors. Funding from private wealthy parties that are also environmentally conscious can assist in this process as well. Cooperation from private sector companies like Tesla whose rocket technology can go hand-in-hand with composting facilities to produce fuel sources and materials; will lead the way into the future. Not only that, but the byproducts from these composting processes can provide a carbon-negative fertilization solution and end the destruction of our soils in the process.

At Key to Life Supply, we imagine a great cooperation between the best and the brightest to help us move into the future. We envision a world that is not only sustainable for the next generation but filled with like-minded people who are forward-thinking and who cooperate with one another to maintain the amazing potential of the natural world. We invite you to become part of this movement however you can. Whether that means making different choices at the grocery store, supporting your local organic farmer, or financially supporting organizations that focus on environmentally conscious practices and restoring the natural environment, any small decision you make will collectively contribute to great change.

New York, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The Cannabis Society is pleased to announce that they are hosting a worldwide hybrid conference covering two distinct topics: European Medical Cannabis and North American MSO Growth and Consolidation on Tuesday, September 21st, 2021. This one-day conference will start with discussions surrounding European Medical Cannabis and move into North American MSO Growth and Consolidation in the afternoon. 

The Anantara Chiang Mai resort in Thailand has launched ‘healthy and nutrition-rich’ cannabis-infused food and drink at its on-site restaurant. Jenny Southan reports

Veterans in vulnerable subgroups are at a higher risk of developing cannabis use disorder (CUD) or consuming cannabis for adult (recreational or non-medical) use, according to a new study from researchers at Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center.

The results indicate the prevalence of CUD and adult cannabis use over the past twelve months to be 1.8 per cent and 7.3 per cent, respectively, whereas lifetime prevalence clocked in at 5.7 per cent and 32.5 per cent. Past 12-month and lifetime CUD prevalence in adult cannabis consumers were calculated at 24.4 per cent and 17.4 per cent, respectively.Researchers also found correlations between CUD and/or nonmedical cannabis use and certain sociodemographic groups, including those who earn a lower income, are male, are young, are single (unmarried), and reside in a state with established medical cannabis legislation.

“Nonmedical cannabis use and use disorder were associated with most psychiatric and substance use disorders examined,” the authors note.

Lead author Kendall C. Browne, Ph.D., concluded that the findings are indicative of a need for increased screening and resources for veterans at a higher risk of developing CUD.

“Among veterans, the odds of nonmedical cannabis use and use disorder were elevated among vulnerable subgroups, including those with lower income or psychiatric disorders and among survey participants residing in states with medical marijuana laws,” Browne concluded.  “The study findings highlight the need for clinical attention (e.g., screening, assessment) and ongoing monitoring among veterans in the context of increasing legalization of cannabis.”